The FDA has updated its alert regarding Boston Scientific’s call for providers to check the connections of their patients’ implanted defibrillators, where calcification growth over time can prevent ...
Certain Boston Scientific defibrillation leads are subject to potential shock coil calcification that can result in reduced shock efficacy, according to an alert released by the company, the Heart ...
The Food and Drug Administration (FDA) said on Wednesday it is monitoring a potential safety issue involving Boston Scientific Corporation’s (NYSE:BSX) ENDOTAK RELIANCE defibrillation leads, following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback